Abstract

The authors studied the results of a randomized controlled trial in which patients who underwent percutaneous transluminal angioplasty either received centered endovascular gamma irradiation or were in a control group. Patients were evaluated at various time-points with intra-arterial angiography, duplex ultrasonography, treadmill tests, and were also interviewed and the results were analyzed. At baseline the two groups had similar characteristics. The rates of target lesion restenosis at 6 and 12 months were significantly lower in the irradiation group. The authors concluded that patients who had endovascular irradiation after angioplasty of de novo femoropopliteal stenosis had a significantly reduced degree of stenosis at 6 and 12. Target vessel retreatment was more frequent in the irradiation group.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call